Overview
- Tatiana Schlossberg, 35, publicly disclosed in The New Yorker that she has terminal acute myeloid leukemia with a rare inversion 3 mutation.
- She was diagnosed on May 25, 2024, just hours after giving birth to her second child, following a white blood cell count of 131,000 per microliter.
- Her treatment included intensive chemotherapy, two bone‑marrow transplants (from her sister and later an anonymous donor), and a CAR‑T clinical trial that produced only temporary remission.
- Complications described include severe cytokine release syndrome requiring high‑flow oxygen, graft‑versus‑host disease, and a late‑September Epstein–Barr virus infection that damaged her kidneys and required rehabilitation.
- She criticizes HHS Secretary Robert F. Kennedy Jr., citing antivaccine positions, research funding cuts affecting institutions including Columbia, and fears over continued access to vaccines and cancer therapies.